Kinematic Analysis in Stroke Patients Using Microsoft Kinect and Akira Software: Kinect-Akira Movement Study
NCT ID: NCT04464863
Last Updated: 2020-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
140 participants
OBSERVATIONAL
2020-01-29
2021-06-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Kinect-based Upper Limb Rehabilitation System in Stroke Patients
NCT02066116
Rapid Movement Therapy for Stroke Rehabilitation
NCT03183635
Multicenter Rehabilitation Study in Acute Stroke
NCT00849303
Impact of a Focal Muscle Vibration Protocol in Front of the the Anterior Tibial Muscle in the Subacute Post-stroke Period on Motor Recovery in Hemiplegic Patients.
NCT04737018
Clinical Application of Cross-education During Stroke Rehabilitation
NCT02948725
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cases
Acute stroke patients during the first week of evolution
Kinematic metrics
kinematic metrics recorded with Kinect (register brand) and extracted with Akira (register brand)
Control
Age and sex 1:1 healthy participants
Kinematic metrics
kinematic metrics recorded with Kinect (register brand) and extracted with Akira (register brand)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kinematic metrics
kinematic metrics recorded with Kinect (register brand) and extracted with Akira (register brand)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Neurological deficit present at the moment of the evaluation.
* Informed consent signed.
Exclusion Criteria
* Aphasia or cognitive decline that prevents the understanding of the workout.
* Refuse to participate
* Previous neurological or osteomuscular conditions.
* Previous conditions with less than 3 months of expectancy of life.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Investigación Hospital Universitario La Paz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
María Alonso de Leciñana, MD PhD
Role: STUDY_DIRECTOR
Hospital Universitario La Paz, IdiPAZ
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
La Paz University Hospital, IdiPAZ
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KAM-Study (PI-3787)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.